维普中文期刊产品整合服务
14篇 您的检索式:作者名="Biomarkers Definitions Working Group"
    题名 作者 年代 出处 被引量
1Biomarkers and surrogate end points: preferred definitions and conceptual framework 显示文摘Biomarkers Definitions Working Group 2001Clin Pharmacol Ther2001,69,3:1
2Biomarkers and surrogate endpoints: preferred definitions and conceptual framework显示文摘Biomarker Definitions Working Group 2001Clin Pharmacol Ther2001,69,3:1
3Biomarkers and surrogate endpoints: preferred definitions and conceptual framework 显示文摘Biomarkers Definitions Working Group 2001Clin Pharmacol Ther2001,69,3:1
4Biomarkers and surrogate endpoints : preferred definitions and conceptual framework 显示文摘Biomarkers Definitions Working Group 2001Clin Pharmacol Ther2001,69,3:1
5Biomarkers and surrogate endpoints:preferred definitions and conceptual framework显示文摘Biomarkers Definitions Working Group 0,,03:1
6Biomarkers and sur- rogate endpoints: preferred definitions and conceptual frame- work显示文摘Biomarkers Definitions Working Group 2001Clin Pharmacol Ther2001,69,3:1
7Biomarkers andsurrogate endpoints:preferred definitions and conceptual framework显示文摘Biomarkers Definition Working Group 0,,:1
8Biomarkers and surrogate endpoints:preferred definitions and conceptual framework显示文摘Biomarkers Definitions Working Group 2001Clin Pharmacol Ther2001,69,3:1
9Biomarkers and surrogate end- points: preferred definition and conceptual framework显示文摘Biomarkers Definitions Working Group 2001Clin Phar- macol Ther2001,69,3:1
10Biomarkers and surrogate endpoints : preferred definitions and conceptual framework 显示文摘Biomarkers Definitions Working Group 2001Clin Pharmacol Ther2001,69,3:1
11Biomarkers and surrogateendpoints: preferred definitions and conceptual framework 显示文摘Biomarkers Definitions Working Group 2001ClinPharmacol Ther2001,69,:1
12Biomarkers and surrogate endpoints : preferred definitions and conceptual framework 显示文摘Biomarkers Definitions Working Group 2001Clin Pharmacol Ther2001,69,3:1
13Biomarkers and surrogate endpoints: preferred definitions and conceptual framework显示文摘BIOMARKERS DEFINITIONS WORKING GROUP 2001Clin Pharmacol Ther2001,69,3:1
14Biomarkers and surrogate end points: preferred definitions and eonceptual framework 显示文摘Biomarker Definitions Working Group 2001Clin Pharmacol Ther2001,69,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费